sellWeak cluster of 2
Harry Shuman sold $3,068 of MRUS
VP Controller, PAO at Merus N.V.. 115 shares at an average of $26.68, traded Dec 19, 2023, filed Dec 20, 2023.
Warning score
23Value
$3,068
115 shares
Holdings after
7,002
-2% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$3k at market
- 0Share of holdings soldSold 1.6% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001209191-23-059328, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 19, 2023 | SOpen-market sale Common Shares | -115 | $26.68 | $3,068 | 7,002 | Dec 20, 2023 |
Related signals
Other insiders at Merus N.V. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 47Moderate | MRUSbuy Merus N.V. | A/s Genmab owner | $7.5B 76,922,983 shares | +106% | |
| 37Weak | MRUSbuy Merus N.V. | A/s Genmab owner | $79M 815,444 shares | +1% | |
| 32Weak | MRUSbuy Merus N.V. | A/s Genmab owner | $27M 278,441 shares | +0% | |
| 27Weak | MRUSbuy Merus N.V. | A/s Genmab owner | $26M 271,547 shares | +0% | |
| 16Weak | MRUSsell Merus N.V. | Harry Shuman VP Controller, PAO | $163k 1,700 shares | -13% | |
| 32Weak | MRUSsell Merus N.V. | Harry Shuman VP Controller, PAO | $796k 8,300 shares | -43% | |
| 30Weak | Merus N.V. | Peter B. Silverman COO & GC | $1.5M 25,000 shares | -100% | |
| 30Weak | Merus N.V. | Peter B. Silverman COO & GC | $1.3M 23,500 shares | -351% | |
| 30Weak | Merus N.V. | Peter B. Silverman COO & GC | $1.8M 34,000 shares | -100% | |
| 33Weak | MRUSsell Merus N.V. | Harry Shuman VP Controller, PAO | $270k 5,000 shares | -53% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.